Literature DB >> 10595564

The extracellular regions of PSMA and the transferrin receptor contain an aminopeptidase domain: implications for drug design.

D Mahadevan1, J W Saldanha.   

Abstract

The Aeromonas proteolytica aminopeptidase (AMP), Pseudomonas sp. (RS-16) carboxypeptidase G2 (CPG2), and Streptomyces griseus aminopeptidase (SGAP) are zinc dependent proteolytic enzymes with cocatalytic zinc ion centers and a conserved aminopeptidase fold. A BLAST search with the sequence of the solved AMP structure indicated that a similar domain could be found in prostate-specific membrane antigen (PSMA) and the transferrin receptor (TfR). When the PSMA or TfR sequence was input into the THREADER program, the top structural matches were SGAP and AMP confirming that these are structurally conserved domains. Optimal sequence alignment of PSMA and TfR using the known three-dimensional structures of AMP, CPG2, and SGAP shows that the critical amino acids involved in forming the catalytic pocket are conserved in PSMA but absent in the TfR. The specificity pocket in AMP is formed from four aromatic side chains and the equivalent region in CPG2/PSMA has a changed sequence pattern. Since CPG2 and PSMA are folate hydrolases, the changed specificity pocket leaves space to accommodate the large pteroate moiety of folic acid. In contrast, no enzyme function has been ascribed to the TfR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595564      PMCID: PMC2144216          DOI: 10.1110/ps.8.11.2546

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  10 in total

Review 1.  GCPII imaging and cancer.

Authors:  C A Foss; R C Mease; S Y Cho; H J Kim; M G Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 2.  NAAG, NMDA receptor and psychosis.

Authors:  Richard Bergeron; Joseph T Coyle
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 3.  PET imaging in prostate cancer: focus on prostate-specific membrane antigen.

Authors:  Ronnie C Mease; Catherine A Foss; Martin G Pomper
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

4.  Change in substrate preference of Streptomyces aminopeptidase through modification of the environment around the substrate binding site.

Authors:  Jiro Arima; Yoshiko Uesugi; Masaki Iwabuchi; Tadashi Hatanaka
Journal:  Appl Environ Microbiol       Date:  2006-10-06       Impact factor: 4.792

5.  Molecular evolution of the transferrin receptor/glutamate carboxypeptidase II family.

Authors:  Lisa Ann Lambert; Stacey L Mitchell
Journal:  J Mol Evol       Date:  2006-12-09       Impact factor: 2.395

6.  Heterologous expression and purification of Vibrio proteolyticus (Aeromonas proteolytica) aminopeptidase: a rapid protocol.

Authors:  Mariam Hartley; Wei Yong; Brian Bennett
Journal:  Protein Expr Purif       Date:  2009-02-20       Impact factor: 1.650

Review 7.  The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Authors:  James C Evans; Meenakshi Malhotra; John F Cryan; Caitriona M O'Driscoll
Journal:  Br J Pharmacol       Date:  2016-09-23       Impact factor: 8.739

8.  Evolution of the iron-responsive element.

Authors:  Paul Piccinelli; Tore Samuelsson
Journal:  RNA       Date:  2007-05-18       Impact factor: 4.942

9.  Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer.

Authors:  Yawen Li; Ming-Kuan Chyan; Donald K Hamlin; Holly Nguyen; Robert Vessella; D Scott Wilbur
Journal:  Nucl Med Biol       Date:  2020-05-03       Impact factor: 2.408

10.  Enhanced thermal stability and hydrolytic ability of Bacillus subtilis aminopeptidase by removing the thermal sensitive domain in the non-catalytic region.

Authors:  Xinxing Gao; Zhongmei Liu; Wenjing Cui; Li Zhou; Yaping Tian; Zhemin Zhou
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.